EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Decreased Expression by a Chemically Modified siRNA to PTBP1 Seriously Affects Warburg Effect in Colorectal Cancer Cells

Keita Matsumoto iD, Hirokatsu Hayashi, Yoshihisa Tokumaru iD, Seito Fujibayashi, Noriki Mitsui, Masahide Endo, Takeshi Horaguchi, Yuji Hatanaka, Ryoma Yokoi, Chika Mizutani, Masashi Kuno, Masahiro Fukada und 8 weitere

Cancer Science · 2026-11 · 117 (11) · 3052-3070

DOI: 10.1111/cas.70491 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, online erschienen am 10.08.2026. Verfasst von Keita Matsumoto und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Gifu University, Gifu, Japan. Hauptthemen laut MEDLINE: Polypyrimidine Tract-Binding Protein, Heterogeneous-Nuclear Ribonucleoproteins, Colorectal Neoplasms, RNA, Small Interfering. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Chugai Pharmaceutical, eNA-biotec.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cells preferentially rely on aerobic glycolysis, known as the Warburg effect, to support growth and survival. We previously demonstrated that polypyrimidine tract–binding protein 1 (PTBP1) maintains PKM2 dominance by regulating pyruvate kinase isoform splicing, sustaining the Warburg phenotype. PTBP1 suppression shifts metabolism toward PKM1 dominance, enhancing oxidative phosphorylation, reactive oxygen species (ROS) production, apoptosis, and antitumor immunity. Thirteen chemically modified siR‐PTBP1 derivatives targeting either the coding region or the 3′‐untranslated region (3′‐UTR) of PTBP1 mRNA were synthesized and evaluated in colorectal cancer cell lines. Cytotoxicity, protein expression, oxidative stress, and metabolic alterations were assessed using cell‐based assays, immunoblotting, and metabolomic analysis. siRNA stability was evaluated following nuclease exposure and quantified by TaqMan RT‐qPCR. siRNAs targeting the 3′‐UTR more effectively suppressed PTBP1 expression and increased the PKM1/PKM2 ratio than coding‐region–targeting siRNAs. Among them, derivative 2‐6 showed the strongest cytotoxicity with oxidative stress and apoptosis. Metabolomic profiling demonstrated altered glycolytic flux and preserved pentose phosphate pathway intermediates with activated redox responses, while adenylate and guanylate energy charges remained viable, indicating metabolic stress without energy collapse. Tricarboxylic acid cycle metabolites were elevated, consistent with enhanced oxidative phosphorylation. Derivative 2‐6 showed resistance to nuclease‐mediated degradation. Direct PKM2 knockdown did not induce comparable cytotoxicity. Chemically modified siR‐PTBP1, particularly derivative 2‐6, induces a metabolically vulnerable state characterized by oxidative imbalance, leading to apoptosis. These findings identify PTBP1 as a key regulator of the Warburg effect and support siRNA‐based metabolic targeting as a therapeutic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polypyrimidine Tract-Binding ProteinHeterogeneous-Nuclear RibonucleoproteinsColorectal NeoplasmsRNA, Small InterferingWarburg Effect, OncologicHumansCell Line, TumorOxidative StressApoptosisGene Expression Regulation, NeoplasticGlycolysisMetabolic Reprogramming3' Untranslated RegionsReactive Oxygen Species

Stichwörter der Autor:innen

PTBP1Warburg effectcolorectal cancermetabolic reprogrammingsiRNA therapeutics

Substanzen

Polypyrimidine Tract-Binding ProteinPTBP1 protein, humanHeterogeneous-Nuclear RibonucleoproteinsRNA, Small Interfering3' Untranslated RegionsReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Gastroenterological Surgery, Gifu University, Gifu, Japan.
  • Department of Breast Oncology and Breast Reconstruction, Chubu International Medical Center, Minokamo, Japan.
  • eNA-biotec, Gifu, Japan.

ORCID-Profile: Keita Matsumoto, Yoshihisa Tokumaru, Yoshihiro Tanaka

Förderung

  • Chugai Pharmaceutical
  • eNA-biotec

Zitieren

APA

Matsumoto, K., Hayashi, H., Tokumaru, Y., Fujibayashi, S., Mitsui, N., Endo, M., Horaguchi, T., Hatanaka, Y., Yokoi, R., Mizutani, C., Kuno, M., Fukada, M., Asai, R., Yasufuku, I., Sato, Y., Tajima, J. Y., Tanaka, Y., Nakashima, R., Akao, Y., & Matsuhashi, N. (2026). Decreased Expression by a Chemically Modified siRNA to PTBP1 Seriously Affects Warburg Effect in Colorectal Cancer Cells. Cancer Science, 117(11), 3052-3070. https://doi.org/10.1111/cas.70491

Vancouver

Matsumoto K, Hayashi H, Tokumaru Y, Fujibayashi S, Mitsui N, Endo M, et al. Decreased Expression by a Chemically Modified siRNA to PTBP1 Seriously Affects Warburg Effect in Colorectal Cancer Cells. Cancer Science. 2026;117(11):3052-3070. doi:10.1111/cas.70491

BibTeX
@article{Matsumoto2026,
  author = {Matsumoto, Keita and Hayashi, Hirokatsu and Tokumaru, Yoshihisa and Fujibayashi, Seito and Mitsui, Noriki and Endo, Masahide and Horaguchi, Takeshi and Hatanaka, Yuji and Yokoi, Ryoma and Mizutani, Chika and Kuno, Masashi and Fukada, Masahiro and Asai, Ryuichi and Yasufuku, Itaru and Sato, Yuta and Tajima, Jesse Yu and Tanaka, Yoshihiro and Nakashima, Remi and Akao, Yukihiro and Matsuhashi, Nobuhisa},
  title = {Decreased Expression by a Chemically Modified siRNA to PTBP1 Seriously Affects Warburg Effect in Colorectal Cancer Cells},
  journal = {Cancer Science},
  year = {2026},
  volume = {117},
  number = {11},
  pages = {3052--3070},
  doi = {10.1111/cas.70491}
}
Kostenlos starten →